• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性胸腔积液的诊断与治疗

Diagnosis and treatment of malignant pleural effusion.

作者信息

Hausheer F H, Yarbro J W

出版信息

Cancer Metastasis Rev. 1987;6(1):23-40. doi: 10.1007/BF00047607.

DOI:10.1007/BF00047607
PMID:2439221
Abstract

Pleural effusion is a common and important complication of malignancy which may at times be difficult to diagnose or treat. Its well recognized association with numerous diseases plus the limitations of our usual diagnostic tests may occasionally cause difficulty. In the oncology patient there are a number of common medical problems associated with the development of pleural effusion which frequently coexist with the malignancy. Pleural effusion may be a presenting or late sign of cancer, and when recurrent can be a vexing symptomatic problem. Fortunately, an increasing number of effective diagnostic and therapeutic modalities are available which, when judiciously applied, facilitate our approach.

摘要

胸腔积液是恶性肿瘤常见且重要的并发症,有时可能难以诊断或治疗。其与众多疾病的明确关联以及我们常用诊断测试的局限性,偶尔会导致困难。在肿瘤患者中,有许多与胸腔积液发生相关的常见医学问题,这些问题常与恶性肿瘤并存。胸腔积液可能是癌症的首发或晚期症状,复发时可能是一个棘手的症状问题。幸运的是,现在有越来越多有效的诊断和治疗方法,若能合理应用,将有助于我们的诊治。

相似文献

1
Diagnosis and treatment of malignant pleural effusion.恶性胸腔积液的诊断与治疗
Cancer Metastasis Rev. 1987;6(1):23-40. doi: 10.1007/BF00047607.
2
Diagnosis and treatment of malignant pleural effusion.恶性胸腔积液的诊断与治疗
Semin Oncol. 1985 Mar;12(1):54-75.
3
Pleural effusions. 2. Definitive evaluation of the exudate.胸腔积液。2. 渗出液的确定性评估。
Postgrad Med. 1986 Oct;80(5):181-8. doi: 10.1080/00325481.1986.11699567.
4
[Diagnostic contribution of the determination of CEA, pH, glucose and lactase dehydrogenase in the pleural fluid in patients with mesothelioma].
Minerva Med. 1987 Mar 15;78(5):317-9.
5
Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.通过结合临床、放射学和胸水分析参数预测恶性及准恶性胸腔积液
Lung. 2017 Oct;195(5):653-660. doi: 10.1007/s00408-017-0032-3. Epub 2017 Jun 27.
6
Effectiveness of medical thoracoscopy and thoracoscopic talc poudrage in patients with exudative pleural effusion.内科胸腔镜及胸腔镜滑石粉喷洒术在渗出性胸腔积液患者中的疗效
Singapore Med J. 2015 May;56(5):268-73. doi: 10.11622/smedj.2015075.
7
Current concepts in diagnosing the cause of pleural effusion.
Geriatrics. 1977 Oct;32(10):44-8.
8
[A case of malignant pleural mesothelioma presenting as pneumothorax].[一例以气胸为表现的恶性胸膜间皮瘤病例]
Nihon Kyobu Shikkan Gakkai Zasshi. 1991 Apr;29(4):477-81.
9
Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma.胸腔积液中透明质酸浓度作为恶性间皮瘤的诊断辅助手段。
Chest. 1988 Nov;94(5):1037-9. doi: 10.1378/chest.94.5.1037.
10
Usefulness of carcinoembryonic antigen in pleural effusion diagnosis.癌胚抗原在胸腔积液诊断中的应用价值。
Chest. 1998 May;113(5):1425-6. doi: 10.1378/chest.113.5.1425-a.

引用本文的文献

1
A Combination of Ultrasound Characteristics with Macroscopic and Biochemical Features to Diagnose the Etiology of Lymphocytic Pleural Effusions.结合超声特征与宏观及生化特征诊断淋巴细胞性胸腔积液的病因
Diagnostics (Basel). 2023 Nov 22;13(23):3502. doi: 10.3390/diagnostics13233502.
2
Video assisted thoracoscopic and open chest surgery in diagnosis and treatment of malignant pleural diseases.电视辅助胸腔镜及开胸手术在恶性胸膜疾病诊断与治疗中的应用
J Vis Surg. 2017 Jun 22;3:85. doi: 10.21037/jovs.2017.05.05. eCollection 2017.
3
Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: a case report with brief review of immunomarkers.

本文引用的文献

1
Landmarks in simple pleural effusions.单纯性胸腔积液的标志性特征。
JAMA. 2014 Jun 18;311(23):2444. doi: 10.1001/jama.2013.279594.
2
Recognition of infrapulmonary pleural effusion.肺下胸膜腔积液的识别。
Radiology. 1960 Jan;74:34-41. doi: 10.1148/74.1.36.
3
ASBESTOS EXPOSURE AND NEOPLASIA.石棉暴露与肿瘤形成
积液细胞学中的腺癌细胞作为诊断陷阱及其对临床管理的潜在影响:一例病例报告并简要回顾免疫标志物
Diagn Cytopathol. 2014 Mar;42(3):253-8. doi: 10.1002/dc.22915. Epub 2012 Nov 16.
4
An update in the management of malignant pleural effusion.恶性胸腔积液管理的最新进展。
Indian J Palliat Care. 2011 May;17(2):98-103. doi: 10.4103/0973-1075.84529.
5
Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology.针对恶性病因导致的复发性胸腔积液的手术及其他侵入性治疗方法。
Support Care Cancer. 2008 Dec;16(12):1323-31. doi: 10.1007/s00520-008-0405-5. Epub 2008 Feb 8.
6
Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer.米托蒽醌胸膜固定术用于缓解卵巢癌继发的恶性胸腔积液。
BMC Palliat Care. 2004 Sep 9;3(1):4. doi: 10.1186/1472-684X-3-4.
7
Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer.米托蒽醌用于乳腺癌恶性胸腔积液化学性胸膜固定术的结果
World J Surg Oncol. 2004 May 20;2:16. doi: 10.1186/1477-7819-2-16.
JAMA. 1964 Apr 6;188:22-6. doi: 10.1001/jama.1964.03060270028006.
4
[TALC POUDRAGE OF THE PLEURA UNDER PLEUROSCOPY. RESULTS, INDICATIONS, TECHNIC].[胸腔镜下胸膜滑石粉喷洒。结果、适应症、技术]
J Fr Med Chir Thorac. 1963 Sep-Oct;17:677-92.
5
PLEURECTOMY IN THE TREATMENT OF PLEURAL EFFUSION DUE TO METASTATIC MALIGNANCY.胸膜切除术治疗转移性恶性肿瘤所致胸腔积液
J Thorac Cardiovasc Surg. 1963 Sep;46:322-30.
6
Talc poudrage in the treatment of pleural effusion due to cancer.滑石粉喷洒治疗癌性胸腔积液
Surg Clin North Am. 1962 Dec;42:1521-6. doi: 10.1016/s0039-6109(16)36840-2.
7
The rate of formation and lymphatic removal of fluid in pleural effusions.胸腔积液中液体的形成速率及淋巴清除率。
J Clin Invest. 1963 Feb;42(2):258-62. doi: 10.1172/JCI104712.
8
The treatment of malignant pleural effusions by partial pleurectomy.部分胸膜切除术治疗恶性胸腔积液
Surg Clin North Am. 1963 Feb;43:99-108. doi: 10.1016/s0039-6109(16)36887-6.
9
Treatment of malignant pleural effusions by talc poudrage.滑石粉喷洒治疗恶性胸腔积液
J Am Med Assoc. 1960 Feb 27;172:918-21. doi: 10.1001/jama.1960.03020090030008.
10
Clinical value of measurements of concentration of protein in pleural fluid.
N Engl J Med. 1958 Nov 6;259(19):926-7. doi: 10.1056/NEJM195811062591909.